Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ryvu | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 700.54M | -6x | 0.23 | PLN 30 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.3% Upside | Upgrade to Pro+ | |
Selvita | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 587.38M | -122.1x | 1.09 | PLN 33.10 | 4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.7% Upside | Upgrade to Pro+ | |
Scope Fluidics | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 420.34M | 6.9x | 0.02 | PLN 154.20 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioton SA | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 356.34M | -21.4x | 0.04 | PLN 4.16 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Captor Therapeutics | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 228.89M | -3.9x | -0.14 | PLN 40.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Molecure | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 158.80M | -5.6x | -0.33 | PLN 7.92 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Poltreg | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 145.03M | -7.8x | 0.22 | PLN 30 | -7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomtec | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 94.41M | -9.1x | 1.76 | PLN 6.20 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanogroup | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 83.68M | -16.6x | -0.28 | PLN 2.64 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyenergy | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 77.91M | 37.8x | 0.36 | PLN 2.32 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Urteste | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 74.15M | -24.3x | -0.52 | PLN 52.20 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Readgene | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 67.44M | -111.7x | PLN 5.72 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Sds Optic | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 40.35M | PLN 6.46 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Sygnis | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 39.38M | PLN 1.56 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Genomed | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 34.09M | 17.4x | PLN 25.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Medicofarma Biotech | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 20.94M | -6.5x | 0.38 | PLN 0.31 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stem Cells Spin | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 14.88M | -28.4x | 0.18 | PLN 0.36 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |